English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Singlet-filtered NMR spectroscopy.

MPS-Authors
/persons/resource/persons220779

Mamone,  S.
Research Group of NMR Signal Enhancement, MPI for Biophysical Chemistry, Max Planck Society;

/persons/resource/persons15147

Griesinger,  C.
Department of NMR Based Structural Biology, MPI for biophysical chemistry, Max Planck Society;

/persons/resource/persons206060

Glöggler,  S.
Research Group of NMR Signal Enhancement, MPI for Biophysical Chemistry, Max Planck Society;

External Resource
No external resources are shared
Fulltext (public)

3212427.pdf
(Publisher version), 2MB

Supplementary Material (public)

3212427_Suppl.DC1
(Supplementary material), 60KB

Citation

Mamone, S., Rezaei-Ghaleh, N., Opazo, F., Griesinger, C., & Glöggler, S. (2020). Singlet-filtered NMR spectroscopy. Science Advances, 6(8): eaaz1955. doi:10.1126/sciadv.aaz1955.


Cite as: http://hdl.handle.net/21.11116/0000-0005-C90C-C
Abstract
Selectively studying parts of proteins and metabolites in tissue with nuclear magnetic resonance promises new insights into molecular structures or diagnostic approaches. Nuclear spin singlet states allow the selection of signals from chemical moieties of interest in proteins or metabolites while suppressing background signal. This selection process is based on the electron-mediated coupling between two nuclear spins and their difference in resonance frequency. We introduce a generalized and versatile pulsed NMR experiment that allows populating singlet states on a broad scale of coupling patterns. This approach allowed us to filter signals from proton pairs in the Alzheimer's disease-related b-amyloid 40 peptide and in metabolites in brain matter. In particular, for glutamine/glutamate, we have discovered a long-lived state in tissue without the typically required singlet sustaining by radiofrequency irradiation. We believe that these findings will open up new opportunities to study metabolites with a view on future in vivo applications.